Adherence to guideline‐directed medical treatments in heart failure. A scientific statement of the Heart Failure Association ( HFA ) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy

Gianluigi Savarese, Felix Lindberg, Antonio Cannata, Marianna Adamo, Giuseppe Ambrosio, Pietro Ameri, Markus S. Anker, Magnus Bäck, Antoni Bayes‐Genis, Tuvia Ben Gal, Frieder Braunschweig, Ovidiu Chioncel, Emilia D'Elia, Hassan El‐Tamimi, Gerasimos Filippatos, Nicolas Girerd, Loreena Hill, Ewa Jankowska, Kamlesh Khunti, Basil S. LewisBrenda Moura, Offer Amir, Stefania Paolillo, Massimo Piepoli, Abdulla Shehab, Maggie Simpson, Hadi Skouri, Davide Stolfo, Carlo Gabriele Tocchetti, Cristiana Vitale, Maurizio Volterrani, Stephan von Haehling, Sven Wassmann, Mehmet Birhan Yilmaz, Juan Carlos Kaski, Dobromir Dobrev, Marco Metra, Giuseppe M.C. Rosano

Research output: Contribution to journalArticlepeer-review

Abstract

Heart failure (HF) affects over 60 million individuals globally. Contemporary guideline‐directed medical therapies (GDMT) reduce cardiovascular mortality and HF hospitalizations. However, medication non‐adherence represents a critical barrier limiting real‐world efficacy of GDMT. This scientific statement aims to provide a comprehensive framework for understanding, measuring, and addressing medication non‐adherence in HF management across diverse healthcare settings. Addressing medication non‐adherence requires systematic, multifaceted approaches targeting individual patient barriers while implementing system‐level interventions. Polypills, digital monitoring platforms, enhanced patient education and empowerment, and multidisciplinary care models represent promising strategies to optimize therapeutic adherence and improve clinical outcomes in HF management.
Original languageEnglish
Pages (from-to)1-16
Number of pages16
JournalEuropean Journal of Heart Failure
Early online date9 Nov 2025
DOIs
Publication statusPublished online - 9 Nov 2025

Bibliographical note

© 2025 The Author(s). European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Funding

K.K. is supported by the National Institute for Health and Care Research(NIHR) Applied Research Collaboration East Midlands (ARC EM), NIHR Global Research Centre for Multiple Long Term Conditions, NIHR Cross NIHR Collaboration for Multiple Long Term Conditions, NIHR Leicester Biomedical Research Centre (BRC) and the British Heart Foundation (BHF)Centre of Excellence. D.D. is supported by grants from National Institutes of Health (R01HL136389, R01HL163277, R01HL160992, R01HL165704,R01HL164838, and R01HL176651), the Deutsche Forschungsgemeinschaft (Research Training Group 2989), and the European Union (large-scale network grant no. 965286, MAESTRIA).

Keywords

  • Fixed‐dose combinations
  • Heart failure
  • Guidelines
  • Multidisciplinary
  • Adherence
  • Polypill
  • Education
  • Digital

Fingerprint

Dive into the research topics of 'Adherence to guideline‐directed medical treatments in heart failure. A scientific statement of the Heart Failure Association ( HFA ) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy'. Together they form a unique fingerprint.

Cite this